Vitamin D deficiency is associated with neurocognitive impairment in HIV-infected subjects

[1]  Gallo Loredana,et al.  Prevalence and Associated Factors of Neurocognitive Impairment in HIV-Positive Patients on Effective Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Treatment. , 2018 .

[2]  P. Narciso,et al.  Prevalence and Associated Factors of Neurocognitive Impairment in HIV-Positive Patients on Effective Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Treatment. , 2018, AIDS research and human retroviruses.

[3]  L. Duvillard,et al.  Vitamin D supplementation, bone turnover, and inflammation in HIV-infected patients. , 2018, Medecine et maladies infectieuses.

[4]  H. DeLuca,et al.  Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D , 2018, British journal of clinical pharmacology.

[5]  M. Yin,et al.  Continued Interest and Controversy: Vitamin D in HIV , 2018, Current HIV/AIDS Reports.

[6]  P. Levy,et al.  Vitamin D deficiency and insufficiency among US adults: prevalence, predictors and clinical implications , 2018, British Journal of Nutrition.

[7]  I. Martínez,et al.  Vitamin D in Human Immunodeficiency Virus Infection: Influence on Immunity and Disease , 2018, Front. Immunol..

[8]  R. Ientile,et al.  Health Risks of Hypovitaminosis D: A Review of New Molecular Insights , 2018, International journal of molecular sciences.

[9]  E. Lonn,et al.  Vitamin D and progression of carotid intima‐media thickness in HIV‐positive Canadians , 2018, HIV medicine.

[10]  E. Wolf,et al.  Secondary Hyperparathyroidism in HIV-Infected Patients in Central Europe , 2018, Hormone and Metabolic Research.

[11]  C. Annweiler,et al.  Vitamin D Improves Neurogenesis and Cognition in a Mouse Model of Alzheimer’s Disease , 2018, Molecular Neurobiology.

[12]  S. Lewin,et al.  The end of HIV: Still a very long way to go, but progress continues , 2017, PLoS medicine.

[13]  C. Annweiler,et al.  Associations of lower vitamin D concentrations with cognitive decline and long-term risk of dementia and Alzheimer's disease in older adults , 2017, Alzheimer's & Dementia.

[14]  L. Kingsley,et al.  Vitamin D Status and Kidney Function Decline in HIV-Infected Men: A Longitudinal Study in the Multicenter AIDS Cohort Study. , 2017, AIDS research and human retroviruses.

[15]  P. H. Gois,et al.  Vitamin D and Infectious Diseases: Simple Bystander or Contributing Factor? , 2017, Nutrients.

[16]  G. Mullin,et al.  Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data , 2017, World journal of hepatology.

[17]  L. Haddow,et al.  Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive Patients , 2017, AIDS and Behavior.

[18]  A. Branch,et al.  Severe Vitamin D Deficiency in Human Immunodeficiency Virus-Infected Pregnant Women is Associated with Preterm Birth , 2016, American Journal of Perinatology.

[19]  B. Brew.  Has HIV-associated neurocognitive disorders now transformed into vascular cognitive impairment? , 2016, AIDS.

[20]  T. Littlejohns,et al.  Vitamin D and cognition in older adults: international consensus guidelines. , 2016, Geriatrie et psychologie neuropsychiatrie du vieillissement.

[21]  H. Amièva,et al.  Diabetes and cognitive decline in a French cohort of patients infected with HIV-1 , 2015, Neurology.

[22]  J. Currier,et al.  Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy , 2015, Nutrition Journal.

[23]  J. Hocking,et al.  Vitamin D Deficiency is Common in HIV-Infected Southern Australian Adults , 2015, Antiviral therapy.

[24]  Michael J. Taylor,et al.  Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  R. Rosenberg,et al.  Exploring Substance Use and HIV Treatment Factors Associated with Neurocognitive Impairment among People Living with HIV/AIDS , 2014, Front. Public Health.

[26]  M. Holick,et al.  Vitamin D and neurocognitive function , 2014, Clinical interventions in aging.

[27]  B. Ances,et al.  Identifying Risk Factors for HIV-Associated Neurocognitive Disorders Using the International HIV Dementia Scale , 2013, Journal of Neuroimmune Pharmacology.

[28]  Cynthia Balion,et al.  Vitamin D, cognition, and dementia , 2012, Neurology.

[29]  Hans Förstl,et al.  Vitamin D Deficiency, Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis , 2012, Dementia and Geriatric Cognitive Disorders.

[30]  A. Vaidya,et al.  The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes. , 2012, Metabolism: clinical and experimental.

[31]  I. Grant,et al.  Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder , 2012, Neurology.

[32]  Mardge H. Cohen,et al.  Vitamin D Deficiency in HIV-Infected and HIV-Uninfected Women in the United States , 2011, Journal of acquired immune deficiency syndromes.

[33]  C. Gordon,et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[34]  Jeffrey N. Martin,et al.  Association of vitamin D insufficiency with carotid intima-media thickness in HIV-infected persons. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  Terry L. Jernigan,et al.  HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors , 2010, Journal of NeuroVirology.

[36]  Michael J. Taylor,et al.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy , 2010, Neurology.

[37]  JoAnn E. Manson,et al.  The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know , 2010, The Journal of clinical endocrinology and metabolism.

[38]  M. Folstein,et al.  25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services , 2010, Neurology.

[39]  J. Becker,et al.  Updated research nosology for HIV-associated neurocognitive disorders , 2007, Neurology.

[40]  François Berger,et al.  New clues about vitamin D functions in the nervous system , 2002, Trends in Endocrinology & Metabolism.

[41]  D. Melzer,et al.  Vitamin D and cognitive impairment in the elderly U.S. population. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

[42]  N. Bhat,et al.  Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of AβPP transgenic mice. , 2011, Journal of Alzheimer's disease : JAD.